WELLINGTON MANAGEMENT GROUP LLP

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 902219 Boston, MA

Position in BIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,689,704

+$17,115,147 QoQ

Shares Held

60,249

+2454.0% QoQ

Ownership

0.225%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 397 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 92% None 8%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $7,924,963,064 across 31 Medical Devices names. BIO ranks #16 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	8,167,185	$2,571,356,522
2	EW	Edwards Lifesciences Corp	16,827,967	$1,522,257,889
3	ABT	Abbott Laboratories	8,304,709	$753,569,291
4	STE	STERIS plc	3,502,897	$737,605,017
5	BSX	Boston Scientific Corp	15,301,828	$653,082,016
6	DXCM	Dexcom Inc	8,527,471	$574,325,169
7	MDT	Medtronic plc	6,474,476	$506,498,254
8	LIVN	LivaNova PLC	1,739,167	$143,011,699

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,689,704	60,249	+2454.0%	Shares	Defined	2026-08-14
2025-03-31	$574,557	2,359	+191.2%	Shares	Defined	2025-05-13
2024-12-31	$266,092	810	-91.9%	Shares	Defined	2025-02-12
2024-09-30	$3,351,152	10,016	+56.1%	Shares	Defined	2024-11-14
2024-06-30	$1,751,999	6,415	-10.1%	Shares	Defined	2024-08-14
2024-03-31	$2,467,090	7,133	-9.4%	Shares	Defined	2024-05-15
2023-12-31	$2,543,403	7,877	+820.2%	Shares	Defined	2024-02-12
2023-06-30	$324,526	856	-62.8%	Shares	Defined	2023-08-14
2023-03-31	$1,101,745	2,300	+126.6%	Shares	Defined	2023-05-12
2022-12-31	$426,797	1,015	-14.3%	Shares	Defined	2023-02-13
2022-03-31	$666,864	1,184	+44.2%	Shares	Defined	2022-05-16
2021-06-30	$528,962	821	+54.6%	Shares	Defined	2021-08-16
2021-03-31	$303,291	531	-76.4%	Shares	Defined	2021-05-17
2020-03-31	$788,058	2,248	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.